DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype
Authors
Keywords
Biomarker, CpG island, DLEC1, Histologic type, Intrahepatic cholangiocarcinoma, Methylation, Prognosis
Journal
VIRCHOWS ARCHIV
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-04
DOI
10.1007/s00428-018-02511-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The prognostic impact of differentiation at the invasive front of biliary tract cancer
- (2018) Satoshi Okubo et al. JOURNAL OF SURGICAL ONCOLOGY
- Cell-of-Origin DNA Methylation Signatures Are Maintained during Colorectal Carcinogenesis
- (2018) Felix Bormann et al. Cell Reports
- Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
- (2016) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Pathologic classification of cholangiocarcinoma: New concepts
- (2015) Yasuni Nakanuma et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan
- (2015) Yoshihiro Sakamoto et al. CANCER
- DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer
- (2015) Lian Zhang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Genomic spectra of biliary tract cancer
- (2015) Hiromi Nakamura et al. NATURE GENETICS
- Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type
- (2014) Shinichi Aishima et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
- (2014) John Bridgewater et al. JOURNAL OF HEPATOLOGY
- Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological and molecular features
- (2014) Jau-Yu Liau et al. MODERN PATHOLOGY
- Aberrant DNA Methylation at Genes Associated with a Stem Cell-like Phenotype in Cholangiocarcinoma Tumors
- (2013) R. Sriraksa et al. Cancer Prevention Research
- Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
- (2013) Sumera Rizvi et al. GASTROENTEROLOGY
- Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway
- (2013) Benjamin Goeppert et al. HEPATOLOGY
- Exome sequencing identifies distinct mutational patterns in liver fluke–related and non-infection-related bile duct cancers
- (2013) Waraporn Chan-on et al. NATURE GENETICS
- Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
- (2013) Yuchen Jiao et al. NATURE GENETICS
- Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes
- (2012) Mina Komuta et al. HEPATOLOGY
- Bile-Based Detection of Extrahepatic Cholangiocarcinoma with Quantitative DNA Methylation Markers and Its High Sensitivity
- (2012) So-Hyun Shin et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Exome sequencing of liver fluke–associated cholangiocarcinoma
- (2012) Choon Kiat Ong et al. NATURE GENETICS
- Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity
- (2012) Vincenzo Cardinale World Journal of Gastrointestinal Oncology
- Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression
- (2011) Tsan-Hua Yu et al. MODERN PATHOLOGY
- Frequent Epigenetic Inactivation of Deleted in Lung and Esophageal Cancer 1 Gene by Promoter Methylation in Non–Small-Cell Lung Cancer
- (2010) Youwei Zhang et al. Clinical Lung Cancer
- Staging of intrahepatic cholangiocarcinoma
- (2010) Hari Nathan et al. CURRENT OPINION IN GASTROENTEROLOGY
- Aberrant Promoter Methylation of DLEC1, a Critical 3p22 Tumor Suppressor for Renal Cell Carcinoma, is Associated With More Advanced Tumor Stage
- (2010) Qian Zhang et al. JOURNAL OF UROLOGY
- Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer
- (2010) Justin J-L Wong et al. MODERN PATHOLOGY
- Methylation of the DLEC1 gene correlates with poor prognosis in Japanese lung cancer patients
- (2010) HIDEFUMI SASAKI et al. Oncology Letters
- Prognostic Implications of and Relationship Between CpG Island Hypermethylation and Repetitive DNA Hypomethylation in Hepatocellular Carcinoma
- (2009) H. S. Lee et al. CLINICAL CANCER RESEARCH
- Prognostic molecular markers in cholangiocarcinoma: A systematic review
- (2008) Christopher D. Briggs et al. EUROPEAN JOURNAL OF CANCER
- The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle
- (2008) Guo-Hua Qiu et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now